PHARMACUTICAL CO PRX (NYSE)

$ 14.89
17:39
Change: unch (unch%)
Volume: 459,075

Avg. Volume: 778559
P/E Ratio: 160
EPS (Annual): -0.36
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 34,530
Institutional Shareholders: 89.05%
Last: 14.89
Change: unch (unch%)
Prev. Close: 14.89
Open: 14.87
Day's Range: 14.78 - 15.08
52wk Range: 12.82 - 24.50
Market Value: 491,740
Beta: .92
12-month EPS Change: 0.00%
Total Return Last 12 Months: -31.88%
Total Return Last 3 Years: -44.34%
Total Return Last 5 Years: -74.67%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on PRX

Movers roundup: Par Pharma, Alkermes

Among the stock activity stories for Friday, Aug. 8, from AP Financial News: NEW YORK (AP)_ Shares of Par Pharmaceutical Cos. plunged Friday after the generic drug developer report...READ MORE
Aug 08, 2008 2:50PM
Keywords: PRX, ALKS, HLYS, LAVA

Par Pharma shares dive on 2Q loss, outlook cut

(NEW YORK)Shares of Par Pharmaceutical Cos. plunged Friday after the generic drug developer reported a second-quarter loss and slashed its outlook because of tougher competition and pricing ...READ MORE
Aug 08, 2008 11:07AM
Keywords: PRX, TEVA, BRL

Par Pharmaceuticals slashes full-year guidance

(WOODCLIFF LAKE, N.J.)Generic drug developer Par Pharmaceutical Cos. slashed its full-year profit outlook late Thursday as competition intensifies and sales decline. The company now expects adjusted ful...READ MORE
Aug 08, 2008 9:52AM
Keywords: PRX

Par Pharmaceuticals swings to 2Q loss

(WOODCLIFF LAKE, N.J.)Generic drug developer Par Pharmaceutical Cos. said late Thursday it swung to a second-quarter loss as revenue fell amid more intense competition and lower royalties.READ MORE
Aug 08, 2008 9:49AM
Keywords: PRX

Priceline.com to replace Kemet in S&P MidCap 400

(NEW YORK)Standard & Poor's announced on Wednesday online travel company Priceline.com will replace Kemet Corp. in the S&P MidCap 400 after close of trading Friday.READ MORE
Jul 30, 2008 7:11PM
Keywords: KEM, RAH, PRX, CDR, AGL, LEH, PCLN

Par Pharmaceutical shares rise on generic drug OK

(NEW YORK)Par Pharmaceutical Cos. shares rose Monday after the company said the Food and Drug Administration approved its generic version of Solvay Pharmaceutical's chemotherapy side eff...READ MORE
Jun 30, 2008 8:10PM
Keywords: PRX

Biovail stock falls after analyst cuts rating

(NEW YORK)Shares of drug developer Biovail Corp. sank Friday after a CIBC analyst said generic drug launches will likely keep pressuring the company's revenue and restructuring efforts w...READ MORE
Jun 20, 2008 3:08PM
Keywords: BVF, TEVA, WPI, PRX
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

MYLAN INC -12.30 12.84
TEVA PHARM INDS +11.50 47.92
ALPHARMA INC +47.70 35.14
BARR PHARMA INC +15.40 67.70
WATSON PHARMACE +3.20 30.26